Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gopi Shankar

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
The AAPS Journal|June 25, 2025
Pharmacokinetics and Pharmacodynamics of Nomlabofusp in Non-clinical Studies of Friedreich's AtaxiaFlavia De Toni, Vanessa Ragaglia, Devin Schecter, et al.
Journal of Immunological Methods|July 15, 2004
Recommendations for the design and optimization of immunoassays used in the detection of host antibodies against biotechnology productsAnthony R Mire-Sluis, Yu Chen Barrett, Viswanath Devanarayan, et al.
Journal of Pharmaceutical and Biomedical Analysis|November 11, 2008
Recommendations for the validation of immunoassays used for detection of host antibodies against biotechnology productsGopi Shankar, Viswanath Devanarayan, Lakshmi Amaravadi, et al.
Regulatory Toxicology and Pharmacology : RTP|April 7, 2009
Immunogenicity of biologically-derived therapeutics: assessment and interpretation of nonclinical safety studiesRafael Ponce, Leslie Abad, Lakshmi Amaravadi, et al.
Journal of Clinical Pharmacology|February 27, 2007
Pharmacokinetics and safety of golimumab, a fully human anti-TNF-alpha monoclonal antibody, in subjects with rheumatoid arthritisHonghui Zhou, Haishan Jang, Roy M Fleischmann, et al.
Journal of Immunological Methods|February 16, 2008
Recommendations on risk-based strategies for detection and characterization of antibodies against biotechnology productsEugen Koren, Holly W Smith, Elizabeth Shores, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
The AAPS Journal|June 25, 2025
Pharmacokinetics and Pharmacodynamics of Nomlabofusp in Non-clinical Studies of Friedreich's AtaxiaFlavia De Toni, Vanessa Ragaglia, Devin Schecter, et al.
Journal of Immunological Methods|July 15, 2004
Recommendations for the design and optimization of immunoassays used in the detection of host antibodies against biotechnology productsAnthony R Mire-Sluis, Yu Chen Barrett, Viswanath Devanarayan, et al.
Journal of Pharmaceutical and Biomedical Analysis|November 11, 2008
Recommendations for the validation of immunoassays used for detection of host antibodies against biotechnology productsGopi Shankar, Viswanath Devanarayan, Lakshmi Amaravadi, et al.
Regulatory Toxicology and Pharmacology : RTP|April 7, 2009
Immunogenicity of biologically-derived therapeutics: assessment and interpretation of nonclinical safety studiesRafael Ponce, Leslie Abad, Lakshmi Amaravadi, et al.
Journal of Clinical Pharmacology|February 27, 2007
Pharmacokinetics and safety of golimumab, a fully human anti-TNF-alpha monoclonal antibody, in subjects with rheumatoid arthritisHonghui Zhou, Haishan Jang, Roy M Fleischmann, et al.
Journal of Immunological Methods|February 16, 2008
Recommendations on risk-based strategies for detection and characterization of antibodies against biotechnology productsEugen Koren, Holly W Smith, Elizabeth Shores, et al.
Pageof 4